Rajasthan based ASG Eye Hospitals raises INR 50 crores from Sequoia Capital
Monday January 21, 2013 , 2 min Read
“ASG Eye Hospitals offers expert ophthalmic care for a wide range of ocular sub-specialties. We provide comprehensive diagnosis, treatment and surgical services through our cutting edge technology,” say Dr. Arun Singhvi and Dr.Shashank Gang, Founders, ASG Eye Hospitals. “Ophthalmic care requires highly skilled and trained professionals and ASG provides world-class surgeons having vast surgical experience and expertise," they add. The Founders as well as many specialists at ASG are trained at AIIMS, India’s foremost medical institution.
Abhay Pandey, Managing Director, Sequoia Capital India Advisors said, “ASG Eye Hospitals brings the best technology in healthcare to Tier II and Tier III markets and offers advanced and competent eye care services in the region. The team led by Dr. Arun and Dr. Shashank are highly committed towards building an accomplished healthcare institution focused on patient-centered care.”
Awarded with international achievers award for health excellence 2009-10, ASG Eye Hospitals has successfully treated over 5 lakh patients till date. ASG Eye Hospitals are pioneers of the latest technology of Phacoemulsification and implantation of multifocal IOLs. Specialist treatments at the institute include advanced Vitreo Retinal surgery for treatment of complicated retinal and vitreous disorders, Squint, Oculoplastic surgery which include treatment for different types of eye tumors and cosmetic eye surgery. It has state of the art facility for spectacle removal by one of the fastest available lasik laser machines in the world. The hospitals also have round the clock emergency services for trauma and a 24 hour eye banking facility, for corneal transplantation to remove blindness.
This investment is testimony to the fact that healthcare is definitely going to be a hot sector along with education and investors would be highly interested in anything new and large happening in these segments. The past months have seen investments into Forus ($5 million), Nephroplus, Attune Technologies ($6 million), Suburban Diagnostics ($8 million), Navigene, Nationwide ($4.5 million), Vyome, Condure and many more. Expect a lot more in the healthcare domain in India.
